Abstract: A charging system for executing a charging process during a charging frame is provided. The charging system includes one or more electric vehicles (EV) chargers; a load management system (LMS) capable of controlling the one or more EV chargers; a network system comprising one or more wired or wireless connections for linking the one or more EV chargers to the load management system; and a precision-time energy-based control algorithm for dynamically regulating an output power of the one or more EV chargers to meet a preset charging profile. The charging frame is divided into a plurality of sections and the LMS adjusts the output power of each section for compensating an energy shortage in previous sections.

Abstract: The present invention provides for a novel peptide and method for treating polyglutamine (polyQ) diseases. Also disclosed are related compositions and kits for therapeutic use in the treatment of polyQ diseases.

Abstract: An intervertebral implant frame that is configured to engage a spacer can include a pair of arms that extend longitudinally from a support member such that the arms engage the spacer. The spacer can be made from bone graft, and include a first spacer body made of cortical bone, and a second spacer body made of cancellous bone.

Abstract: An intervertebral implant frame that is configured to be attached to a spacer body can include a pair of arms that extend longitudinally from a support member such that the arms extend substantially around the spacer body. The arms may be configured to expand, crimp, or otherwise engage the spacer body to thereby hold the spacer body to the frame. The spacer body may be made from bone graft.

Abstract: Described is a method and device for detecting a discontinuous transmission state (DTX) at an uplink control information (UCI) receiver device in a wireless communication system. The method involves receiving a linear block encoded signal on an uplink (UL) at said UCI receiver device and processing the received linear block encoded signal after resource element (RE) dernapping to obtain channel estimation data. The method includes determining from said channel estimation data a DTX metric for one or more selected resource blocks (RBs) and determining if a DTX state has occurred by comparing the determined DTX metric to a calculated, selected, or predetermined threshold.

Abstract: Described is a method and device for detecting a discontinuous transmission state (DTX) at an uplink control information (UCI) receiver device in a wireless communication system. The method involves receiving a linear block encoded signal on an uplink (UL) at said UCI receiver device and processing the received linear block encoded signal after resource element (RE) dernapping to obtain channel estimation data. The method includes determining from said channel estimation data a DTX metric for one or more selected resource blocks (RBs) and determining if a DTX state has occurred by comparing the determined DTX metric to a calculated, selected, or predetermined threshold.

Abstract: The present invention provides for a novel peptide inhibitor and method for treating neurological disorders related to a hexanucleotide (GGGGCC) repeat expansion in the non-coding region of the C9ORF72 gene. Also disclosed are related compositions and kits for therapeutic use in the treatment of the pertinent diseases.

Abstract: An intervertebral implant frame that is configured to engage a spacer can include a pair of arms that extend longitudinally from a support member such that the arms engage the spacer. The spacer can be made from bone graft, and include a first spacer body made of cortical bone, and a second spacer body made of cancellous bone.

Abstract: An intervertebral implant frame that is configured to engage a spacer can include a pair of arms that extend longitudinally from a support member such that the arms engage the spacer. The spacer can be made from bone graft, and include a first spacer body made of cortical bone, and a second spacer body made of cancellous bone.

Abstract: An intervertebral implant frame that is configured to be attached to a spacer body can include a pair of arms that extend longitudinally from a support member such that the arms extend substantially around the spacer body. The arms may be configured to expand, crimp, or otherwise engage the spacer body to thereby hold the spacer body to the frame. The spacer body may be made from bone graft.

Abstract: Herein provided are peptide inhibitors and methods for treating polyglutamine (polyQ) diseases. Also disclosed are related compositions and kits for therapeutic use in the treatment of polyQ diseases.

Abstract: An intervertebral implant frame that is configured to be attached to a spacer body can include a pair of arms that extend longitudinally from a support member such that the arms extend substantially around the spacer body. The arms may be configured to expand, crimp, or otherwise engage the spacer body to thereby hold the spacer body to the frame. The spacer body may be made from bone graft.

Abstract: An intervertebral implant frame that is configured to engage a spacer can include a pair of arms that extend longitudinally from a support member such that the arms engage the spacer. The spacer can be made from bone graft, and include a first spacer body made of cortical bone, and a second spacer body made of cancellous bone.

Abstract: The present invention provides for a novel method for treating polyglutamine (polyQ) diseases. Also disclosed are related compositions and kits for therapeutic use in the treatment of polyQ diseases.

Abstract: An intervertebral implant frame that is configured to engage a spacer can include a pair of arms that extend longitudinally from a support member such that the arms engage the spacer. The spacer can be made from bone graft, and include a first spacer body made of cortical bone, and a second spacer body made of cancellous bone.

Abstract: An intervertebral implant frame that is configured to engage a spacer can include a pair of arms that extend longitudinally from a support member such that the arms engage the spacer. The spacer can be made from bone graft, and include a first spacer body made of cortical bone, and a second spacer body made of cancellous bone.

Abstract: The present invention provides for novel peptide inhibitors and methods for treating polyglutamine (polyQ) diseases. Also disclosed are related compositions and kits for therapeutic use in the treatment of polyQ diseases.

Abstract: The present invention provides for a novel peptide inhibitor and method for treating neurological disorders related to a hexanucleotide (GGGGCC) repeat expansion in the non-coding region of the C9ORF72 gene. Also disclosed are related compositions and kits for therapeutic use in the treatment of the pertinent diseases.

Abstract: An intervertebral implant frame that is configured to engage a spacer can include a pair of arms that extend longitudinally from a support member such that the arms engage the spacer. The spacer can be made from bone graft, and include a first spacer body made of cortical bone, and a second spacer body made of cancellous bone.

Abstract: An intervertebral implant frame that is configured to be attached to a spacer body can include a pair of arms that extend longitudinally from a support member such that the arms extend substantially around the spacer body. The arms may be configured to expand, crimp, or otherwise engage the spacer body to thereby hold the spacer body to the frame. The spacer body may be made from bone graft.